Loading...

Teladoc Health, Inc. Peer Comparison

Metric Value Ranking
Market Cap $2.2 Billion 3/9 VEEV
$37.9B
DOCS
$14.1B
TDOC
$2.2B
PGNY
$1.9B
GDRX
$1.8B
SDGR
$1.7B
TXG
$1.4B
TALK
$675.7M
ACCD
$563.6M
Gross Margin 72% 4/9 GDRX
94%
DOCS
90%
VEEV
75%
TDOC
72%
TXG
70%
SDGR
50%
TALK
46%
ACCD
44%
PGNY
21%
Profit Margin -5% 6/9 DOCS
32%
VEEV
27%
GDRX
6%
PGNY
4%
TALK
-3%
TDOC
-5%
TXG
-24%
SDGR
-100%
ACCD
-100%
EBITDA margin -7% 6/9 DOCS
39%
VEEV
26%
GDRX
7%
PGNY
4%
TALK
0%
TDOC
-7%
ACCD
-15%
TXG
-16%
SDGR
-194%
Quarterly Revenue $640.5 Million 2/9 VEEV
$699.2M
TDOC
$640.5M
PGNY
$286.6M
GDRX
$195.3M
TXG
$151.7M
TALK
$138.8M
DOCS
$136.8M
ACCD
$105.1M
SDGR
$35.3M
Quarterly Earnings -$33.3 Million 6/9 VEEV
$185.8M
DOCS
$44.2M
GDRX
$12.3M
PGNY
$10.4M
TALK
-$3.6M
TDOC
-$33.3M
TXG
-$35.8M
SDGR
-$38.1M
ACCD
-$121.3M
Quarterly Free Cash Flow $168.8 Million 1/9 TDOC
$168.8M
VEEV
$164.1M
GDRX
$123.6M
DOCS
$70.1M
PGNY
$42.7M
TXG
$17.8M
TALK
$4.6M
ACCD
-$7.8M
SDGR
-$34.6M
Trailing 4 Quarters Revenue $2.6 Billion 2/9 VEEV
$2.7B
TDOC
$2.6B
PGNY
$1.1B
GDRX
$790.4M
TXG
$629.7M
DOCS
$516.8M
ACCD
$446.7M
TALK
$272.7M
SDGR
$193.3M
Trailing 4 Quarters Earnings -$981.7 Million 9/9 VEEV
$699.2M
TDOC
$640.5M
PGNY
$286.6M
GDRX
$195.3M
TXG
$151.7M
TALK
$138.8M
DOCS
$136.8M
ACCD
$105.1M
SDGR
$35.3M
Quarterly Earnings Growth 42% 4/9 GDRX
132%
TXG
62%
DOCS
44%
TDOC
42%
SDGR
39%
VEEV
37%
TALK
19%
PGNY
-34%
ACCD
-476%
Annual Earnings Growth -289% 9/9 TALK
63%
DOCS
50%
VEEV
42%
TXG
35%
PGNY
-6%
ACCD
-51%
GDRX
-106%
SDGR
-261%
TDOC
-289%
Quarterly Revenue Growth -3% 8/9 TALK
259%
DOCS
20%
VEEV
13%
GDRX
8%
ACCD
6%
PGNY
2%
TXG
-1%
TDOC
-3%
SDGR
-17%
Annual Revenue Growth -1% 9/9 TALK
87%
SDGR
31%
DOCS
18%
ACCD
15%
VEEV
11%
TXG
6%
GDRX
6%
PGNY
2%
TDOC
-1%
Cash On Hand $1.2 Billion 1/9 TDOC
$1.2B
VEEV
$1.0B
GDRX
$423.8M
TXG
$398.2M
ACCD
$185.9M
DOCS
$184.2M
SDGR
$160.4M
TALK
$119.0M
PGNY
$91.5M
Short Term Debt $550.7 Million 1/9 TDOC
$550.7M
SDGR
$16.9M
ACCD
$14.7M
TXG
$9.4M
GDRX
$9.3M
VEEV
$9.2M
DOCS
$2.2M
PGNY
-$0
TALK
-$0
Long Term Debt $1.6 Billion 1/9 TDOC
$1.6B
SDGR
$103.3M
TXG
$76.5M
VEEV
$62.5M
GDRX
$47.7M
ACCD
$21.1M
PGNY
$16.6M
DOCS
$11.3M
TALK
$0
PE -1.00 4/9 DOCS
81.02
VEEV
56.89
PGNY
32.74
TDOC
-1.00
TXG
-1.00
SDGR
-1.00
ACCD
-1.00
GDRX
-1.00
TALK
-1.00
PS 0.83 9/9 DOCS
27.29
VEEV
14.26
SDGR
8.98
TALK
2.48
GDRX
2.33
TXG
2.27
PGNY
1.65
ACCD
1.26
TDOC
0.83
PB 1.43 9/9 DOCS
14.68
VEEV
6.89
TALK
5.75
PGNY
4.31
SDGR
3.86
GDRX
2.64
TXG
1.98
ACCD
1.80
TDOC
1.43
PC 1.74 9/9 DOCS
76.56
VEEV
36.27
PGNY
20.50
SDGR
10.83
TALK
5.68
GDRX
4.34
TXG
3.59
ACCD
3.03
TDOC
1.74
Liabilities to Equity 1.34 1/9 TDOC
1.34
ACCD
1.07
GDRX
0.95
PGNY
0.52
SDGR
0.49
TXG
0.30
TALK
0.18
VEEV
0.17
DOCS
0.16
ROA -0.28 8/9 DOCS
16%
VEEV
10%
PGNY
9%
GDRX
-1%
TALK
-5%
TXG
-19%
SDGR
-27%
TDOC
-28%
ACCD
-28%
ROE -0.65 9/9 DOCS
18%
PGNY
13%
VEEV
12%
GDRX
-1%
TALK
-6%
TXG
-25%
SDGR
-40%
ACCD
-58%
TDOC
-65%
Current Ratio 1.75 9/9 DOCS
7.11
VEEV
6.78
TALK
6.70
TXG
4.36
SDGR
3.04
PGNY
2.93
GDRX
2.06
ACCD
1.94
TDOC
1.75
Quick Ratio 0.62 9/9 DOCS
81.02
VEEV
56.89
PGNY
32.74
TDOC
-1.00
TXG
-1.00
SDGR
-1.00
ACCD
-1.00
GDRX
-1.00
TALK
-1.00
Long Term Debt to Equity 1.05 1/9 TDOC}
1.05
SDGR}
0.23
TXG}
0.11
ACCD}
0.07
GDRX}
0.07
PGNY}
0.04
VEEV}
0.01
DOCS}
0.01
TALK}
0.00
Debt to Equity 1.05 1/9 TDOC
1.05
SDGR
0.27
TXG
0.12
ACCD
0.09
GDRX
0.08
PGNY
0.04
VEEV
0.01
DOCS
0.01
TALK
0.00
Burn Rate 5.31 3/9 TALK
33.10
TXG
9.67
TDOC
5.31
SDGR
3.45
ACCD
1.48
DOCS
-4.27
VEEV
-5.77
PGNY
-9.38
GDRX
-52.78
Cash to Cap 0.58 1/9 TDOC
0.58
ACCD
0.33
TXG
0.28
GDRX
0.23
TALK
0.18
SDGR
0.09
PGNY
0.05
VEEV
0.03
DOCS
0.01
CCR -5.07 9/9 GDRX
10.08
PGNY
4.10
DOCS
1.59
SDGR
0.91
VEEV
0.88
ACCD
0.06
TXG
-0.50
TALK
-1.28
TDOC
-5.07
EV to EBITDA -56.19 9/9 TALK}
5623.21
DOCS}
262.24
VEEV}
203.53
PGNY}
144.50
GDRX}
110.90
SDGR}
-24.80
ACCD}
-25.69
TXG}
-47.23
TDOC}
-56.19
EV to Revenue 0.96 8/9 DOCS
26.96
VEEV
13.89
SDGR
8.78
TALK
2.04
GDRX
1.87
TXG
1.78
PGNY
1.58
TDOC
0.96
ACCD
0.91